CF Industries Holdings (CF) is back in focus after securing a US$169.5 million cash settlement from Orica International and Nelson Brothers. This closes related litigation and refocuses attention on its core fertilizer and clean energy ambitions.

The share price has picked up strongly, with a 30 day share price return of 30.25% and a 90 day share price return of 56.04%, while the 1 year total shareholder return of 65.13% sits on top of solid multi year gains. This suggests that momentum has been building as investors weigh the Orica settlement, blue ammonia pivot and recent buybacks against ongoing antitrust scrutiny and executive pay trends.

If this kind of re rating has your attention, it could be a good moment to see what else is moving in energy related infrastructure through 87 nuclear energy infrastructure stocks

With the stock at US$123.29 after strong recent gains and trading at a discount to the average analyst price target, the key question is whether CF is still undervalued or if the market is already factoring in future growth.

Most Popular Narrative: 26.1% Overvalued

CF Industries is trading at $123.29, well above the most followed narrative fair value of $97.74, which is built on a 7.68% discount rate and cautious top line and margin assumptions.

Substantial capital allocation to shareholder returns $2 billion in buybacks over 12 months and an additional $2.4 billion authorized has inflated EPS and ROE, potentially causing investors to overvalue shares based on recent financial engineering rather than sustainable operating profit trends.

Want to see what is sitting underneath that earnings power story, and how shrinking revenues, thinner margins and fewer shares all feed into this valuation narrative?

Result: Fair Value of $97.74 (OVERVALUED)

However, if tighter nitrogen markets begin to ease or if there are regulatory shifts around low carbon incentives, the current optimism built into CF’s valuation story could be quickly tested.

Another Way To Look At Value

While the popular narrative flags CF Industries as 26.1% overvalued versus a fair value of $97.74, the current 13x P/E tells a different story. That multiple sits well below the US Chemicals industry at 28.2x, the peer average at 28.7x, and even below a 18.2x fair ratio. This could mean more rerating risk than price downside risk if sentiment turns.

To see what the numbers say about this price, take a look at our valuation breakdown through See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With both risks and rewards in play, do you feel the balance of this story is tilted too far in one direction, or not far enough? Move quickly, review the underlying data, and stress test your own thesis against the 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If CF has sharpened your curiosity, now is the time to widen your search and compare it with a few other focused stock ideas.

• Spot potential mispricings by scanning markets for 49 high quality undervalued stocks that combine appealing valuations with stronger fundamentals than you might expect at first glance.
• Strengthen your income watchlist by reviewing 15 dividend fortresses that may appeal if you prioritize cash returns alongside price performance.
• Reduce surprises in your portfolio by checking out 76 resilient stocks with low risk scores that score well on financial health and business stability factors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.